Table of Contents Author Guidelines Submit a Manuscript
International Journal of Medicinal Chemistry
Volume 2015 (2015), Article ID 418362, 9 pages
http://dx.doi.org/10.1155/2015/418362
Research Article

Synthesis and Biological Activity of Arylspiroborate Salts Derived from Caffeic Acid Phenethyl Ester

1Department of Chemistry and Biochemistry, Université de Moncton, Moncton, NB, Canada E1A 3E9
2Department of Biology, University of New Brunswick, Saint John, NB, Canada E2L 4L5
3Department of Chemistry, University of New Brunswick, Fredericton, NB, Canada E3B 5A3
4Department of Chemistry and Biochemistry, Mount Allison University, Sackville, NB, Canada E4L 1G8

Received 27 October 2014; Revised 27 January 2015; Accepted 7 February 2015

Academic Editor: Patrick Bednarski

Copyright © 2015 Martin J. G. Hébert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Miyaura and A. Suzuki, “Palladium-catalyzed cross-coupling reactions of organoboron compounds,” Chemical Reviews, vol. 95, no. 7, pp. 2457–2483, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. M. P. Groziak, “Boron therapeutics on the horizon,” The American Journal of Therapeutics, vol. 8, no. 5, pp. 321–328, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. H.-Z. Hu, Q. Gu, C. Wang et al., “2-Aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3,” Journal of Biological Chemistry, vol. 279, no. 34, pp. 35741–35748, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. J. Baker, J. W. Tomsho, and S. J. Benkovic, “Boron-containing inhibitors of synthetases,” Chemical Society Reviews, vol. 40, no. 8, pp. 4279–4285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Zhang, M. Y. Zhu, Y. N. Lin, and H. C. Zhou, “The synthesis of benzoxaboroles and their applications in medicinal chemistry,” Science China Chemistry, vol. 56, no. 10, pp. 1372–1381, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. C. M. Vogels and S. A. Westcott, “Arylspiroboronate esters: from lithium batteries to wood preservatives to catalysis,” Chemical Society Reviews, vol. 40, no. 3, pp. 1446–1458, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. I. Webb, N. R. Halcovitch, E. G. Bowes et al., “Arylspiroborates derived from 4-tert-butylcatechol and 3,5-di-tert- butylcatechol and their antimicrobial activities,” Journal of Heterocyclic Chemistry, vol. 51, no. 1, pp. 157–161, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. L. M. LeBlanc, A. F. Paré, J. Jean-Francois, M. J. G. Hébert, M. E. Surette, and M. Touaibia, “Synthesis and antiradical/antioxidant activities of caffeic acid phenethyl ester and its related propionic, acetic, and benzoic acid analogues,” Molecules, vol. 17, no. 12, pp. 14637–14650, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. H.-F. Liao, Y.-Y. Chen, J.-J. Liu et al., “Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion and metastasis,” Journal of Agricultural and Food Chemistry, vol. 51, no. 27, pp. 7907–7912, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D. Baranowski, M. P. Davidson, C. W. Nagel, and R. L. Brannen, “Inhibition of Saccharomyces cerevisiae by naturally occurring hydroxy cinnamates,” Journal of Food Science, vol. 45, no. 3, pp. 592–594, 1980. View at Publisher · View at Google Scholar
  11. P. Michaluart, J. L. Masferrer, A. M. Carothers et al., “Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation,” Cancer Research, vol. 59, no. 10, pp. 2347–2352, 1999. View at Google Scholar · View at Scopus
  12. L. H. Boudreau, J. Maillet, L. M. LeBlanc et al., “Caffeic acid phenethyl ester and its amide analogue are potent inhibitors of leukotriene biosynthesis in human polymorphonuclear leukocytes,” PLoS ONE, vol. 7, no. 2, Article ID e31833, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Berger, M. T. M. De Chandt, and C. B. Cairns, “Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease,” International Journal of Clinical Practice, vol. 61, no. 4, pp. 663–676, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. C. Liu, L. M. Dube, J. Lancaster, L. J. Swanson, L. Rosenstein, and M. McConnell, “Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial,” Journal of Allergy and Clinical Immunology, vol. 98, no. 5, pp. 859–871, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Mehrabian, H. Allayee, J. Wong et al., “Identification of 5-Lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice,” Circulation Research, vol. 91, no. 2, pp. 120–126, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. J. A. Leff, W. W. Busse, D. Pearlman et al., “Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction,” The New England Journal of Medicine, vol. 339, no. 3, pp. 147–152, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Chen, B. K. Lam, Y. Kanaoka et al., “Neutrophil-derived leukotriene B4 is required for inflammatory arthritis,” Journal of Experimental Medicine, vol. 203, no. 4, pp. 837–842, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Bruckner, Advanced Organic Chemistry: Reaction Mechanisms, Harcourt/Academic Press, San Diego, Calif, USA, 2002.
  19. B. Burja, M. Kočevar, and S. Polanc, “A simple approach to pyrazol-3-ones via diazenes,” Tetrahedron, vol. 65, no. 42, pp. 8690–8696, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Kunesch, C. Miet, and J. Poisson, “Utilisation de la guanidine comme agent désacétylant sélectif: une méthode de désacétylation instantanée applicable aux sucres,” Tetrahedron Letters, vol. 28, no. 31, pp. 3569–3572, 1987. View at Publisher · View at Google Scholar · View at Scopus
  21. C.-F. Lin, T.-C. Chang, C.-C. Chiang, H.-J. Tsai, and L.-Y. Hsu, “Synthesis of selenium-containing polyphenolic acid esters and evaluation of their effects on antioxidation and 5-lipoxygenase inhibition,” Chemical and Pharmaceutical Bulletin, vol. 53, no. 11, pp. 1402–1407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. L. H. Boudreau, N. Picot, J. Doiron et al., “Caffeoyl and cinnamoyl clusters with anti-inflammatory and anti-cancer effects. Synthesis and structure-activity relationship,” New Journal of Chemistry, vol. 33, no. 9, pp. 1932–1940, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Pergola, B. Jazzar, A. Rossi et al., “Cinnamyl-3,4-dihydroxy-α-cyanocinnamate is a potent inhibitor of 5-lipoxygenase,” Journal of Pharmacology and Experimental Therapeutics, vol. 338, no. 1, pp. 205–213, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Akita, M. Nozawa, A. Mitsuda, and H. Ohsawa, “A convenient synthesis of (+)-albicanol based on enzymatic function: Total syntheses of (+)-albicanyl acetate, (-)-albicanyl 3,4-dihydroxycinnamate, (-)-drimenol, (-)-drimenin and (-)-ambrox,” Tetrahedron Asymmetry, vol. 11, no. 6, pp. 1375–1388, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. M. W. B. McCulloch, F. Berrue, B. Haltli, and R. G. Kerr, “One-pot syntheses of pseudopteroxazoles from pseudopterosins: a rapid route to non-natural congeners with improved antimicrobial activity,” Journal of Natural Products, vol. 74, no. 10, pp. 2250–2256, 2011. View at Publisher · View at Google Scholar · View at Scopus